267 related articles for article (PubMed ID: 21282321)
1. Intrathecal baclofen in multiple sclerosis: too little, too late?
Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study.
Khan AA; Birks-Agnew I; Bullock P; Rushton D
NeuroRehabilitation; 2010; 27(2):117-20. PubMed ID: 20871140
[No Abstract] [Full Text] [Related]
3. Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.
Nelson MES; McGuire JR
Neuromodulation; 2019 Oct; 22(7):839-842. PubMed ID: 31157471
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
[TBL] [Abstract][Full Text] [Related]
5. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
[TBL] [Abstract][Full Text] [Related]
7. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
[TBL] [Abstract][Full Text] [Related]
8. [New treatment for spasticity--intrathecal baclofen therapy].
Nemoto A; Sakata K
Nihon Rinsho; 2008 Apr; 66(4):789-99. PubMed ID: 18409533
[TBL] [Abstract][Full Text] [Related]
9. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal baclofen therapy: ten steps toward best practice.
Ridley B; Rawlins PK
J Neurosci Nurs; 2006 Apr; 38(2):72-82. PubMed ID: 16681287
[TBL] [Abstract][Full Text] [Related]
11. Functional outcome of intrathecal baclofen administration for severe spasticity.
Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
[TBL] [Abstract][Full Text] [Related]
12. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
Sampson FC; Hayward A; Evans G; Morton R; Collett B
J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
[TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal baclofen infusions. An introduction and overview.
Kamensek J
Axone; 1999 Mar; 20(3):67-72. PubMed ID: 10401268
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief.
McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP
Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358
[TBL] [Abstract][Full Text] [Related]
15. [Intrathecal baclofen therapy and management of severe spasticity].
Naito Y
Brain Nerve; 2014 Sep; 66(9):1049-55. PubMed ID: 25200576
[TBL] [Abstract][Full Text] [Related]
16. The incidence and management of tolerance in intrathecal baclofen therapy.
Heetla HW; Staal MJ; Kliphuis C; van Laar T
Spinal Cord; 2009 Oct; 47(10):751-6. PubMed ID: 19333246
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
[TBL] [Abstract][Full Text] [Related]
19. Managing spasticity with intrathecal drug delivery.
Barker E
RN; 2008 Apr; 71(4):24-9; quiz 30. PubMed ID: 18524352
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
